Dashboard
Manage Tickers

FDMT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
11/06/2025 12:05:55

4d-molecular-therapeutics-prices-100m-offering-including-84m-common-shares-at-1051-each-and-11m-pre-funded-warrants-at-105099-each
4D Molecular Therapeutics Prices $100M Off...
11/06/2025 11:31:31

4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and...

4dmts-4d-150-demonstrates-durable-multi-year-benefit-supporting-its-potential-as-a-backbone-therapy-for-wet-amd-and-retinal-diseases
4DMT's 4D-150 Demonstrates Durable, Multi-...
11/06/2025 11:14:51

4D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuit...

reported-earlier-4dmt-and-otsuka-pharmaceutical-sign-85m-upfront-license-deal-with-up-to-336m-in-milestones-to-develop-and-commercialize-4d-150-across-asia-pacific
Reported Earlier, 4DMT And Otsuka Pharmace...
10/31/2025 07:49:40

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over th...

beyond-the-numbers-4-analysts-discuss-4d-molecular-therapeutics-stock
Beyond The Numbers: 4 Analysts Discuss 4D ...
10/21/2025 21:00:57

rbc-capital-reiterates-outperform-on-4d-molecular-therapeutics-maintains-26-price-target
RBC Capital Reiterates Outperform on 4D Mo...
10/21/2025 14:28:01

RBC Capital analyst Lisa Walter reiterates 4D Molecular Therapeutics (NASDAQ:FDMT) with a Outperform and maintains $26 price...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

on-sept-30-4d-molecular-therapeutics-appointed-ashoo-gupta-as-principal-financial-officer-effective-immediately
On Sept 30, 4d Molecular Therapeutics Appo...
10/02/2025 20:12:01

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

jim-cramer-applovin-calls-for-prudence-this-health-care-stock-is-pure-spec
Jim Cramer: AppLovin Calls For Prudence, T...
09/03/2025 11:46:59

Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent,"...

4d-molecular-therapeutics-says-4front-1-phase-3-trial-enrollment-continues-to-exceed-expectations-with-enrollment-completion-now-expected-in-q1-2026
4D Molecular Therapeutics Says 4FRONT-1 Ph...
09/02/2025 12:14:19

what-4-analyst-ratings-have-to-say-about-4d-molecular-therapeutics
What 4 Analyst Ratings Have To Say About 4...
08/12/2025 19:01:25

roth-capital-maintains-buy-on-4d-molecular-therapeutics-lowers-price-target-to-38
Roth Capital Maintains Buy on 4D Molecular...
08/12/2025 17:49:17

Roth Capital analyst Salveen Richter maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and lowers the price targe...

chardan-capital-maintains-buy-on-4d-molecular-therapeutics-maintains-25-price-target
Chardan Capital Maintains Buy on 4D Molecu...
08/12/2025 10:49:51

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and maintains $25 price...

4d-molecular-therapeutics-q2-eps-098-misses-085-estimate-sales-15000k-miss-374143k-estimate
4D Molecular Therapeutics Q2 EPS $(0.98) M...
08/11/2025 12:17:31

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.98) per share which missed the analyst consensus estim...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
08/04/2025 17:06:36

assessing-4d-molecular-therapeutics-insights-from-5-financial-analysts
Assessing 4D Molecular Therapeutics: Insig...
08/01/2025 22:04:04

4d-molecular-therapeutics-rallies-on-heels-of-diabetes-related-vision-study
4D Molecular Therapeutics Rallies On Heels...
08/01/2025 14:29:21

4D Molecular's 4D-150 showed sustained vision and anatomical improvements with fewer injections in DME, supported by regula...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Core News & Articles
Market-Moving News for August 1st
08/01/2025 11:15:14

FIG: 28% | Figma shares are trading higher on momentum following Thursday's IPO. COIN: -11% | Coinbase shares are trading l...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION